進行子宮頚癌に対する集学的治療の現状と問題点

概要

論文の詳細を見る
Rodiotherapy has been adapted as the first treatment for patients with advanced cervical cancer of the uterus, its prognosis is not good enough. To improve the prognosis multidisciplinary therapy combining surgery, chemotherapy and immunotherapy was used. In the present study, therapeutic modality and prognostic factors were examined in 61 patients with inoperable advanced cervical cancer trented during the eighth-year period from 1989to 1996. The percentage of patients surviving at present (up to 30 June 1998) are as follows: with neoadjvant intraarterial chemotherapy was 50 % (3/6 cases), campared without chemotherapy was 45.4% (30/55 cases): with microselectoron was 47.6% (10/21 cases), compared withous microselectoron was 48.6% (18/37 cases): With surgery was 64.7% (22/34 cases), compared without surgery was 22.2% (6/27 cases): with general infravenous chemotherapy was 25.0 % (5/20 cases), compared without chemotherapy was 56.1% (23/41 cases): oral maintenance chemotherapywith 5-FU was 52.9%(9/17cases), with UFT was 47.6%(10/21cases), with FT was 50.0% (6/12 cases): Imunotherapy with SPG was 45.0% (9/20 cases), compared without SPG was 46.3% (19/41cases).
Kinki Brain Tumor Pathology Conferenceの論文